GLP-1 vs Qsymia: Comparing Two Weight Loss Medications

If you're exploring prescription weight loss options, you've likely encountered both GLP-1 medications like semaglutide and Qsymia. Both are FDA-approved for weight management, but they work in fundamentally different ways and come with distinct considerations. Understanding these differences is essential to finding the right approach for your health journey.

Let's break down what sets these medications apart, how they work, and what you need to know to have an informed conversation with your healthcare provider.

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of medications that mimic a naturally occurring hormone in your body called glucagon-like peptide-1. This hormone plays a crucial role in regulating blood sugar and appetite.

The most commonly prescribed GLP-1 medications for weight loss include semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro). These medications were originally developed for type 2 diabetes but have proven remarkably effective for weight management.

How GLP-1 Medications Work

GLP-1s work through multiple mechanisms in your body. They slow down how quickly food leaves your stomach, which helps you feel full longer after eating. They also act on receptors in your brain that regulate appetite, reducing hunger signals and food cravings.

Additionally, GLP-1 medications help regulate blood sugar by stimulating insulin release when glucose levels are elevated and reducing glucagon secretion. This dual action makes them particularly beneficial for people with prediabetes or metabolic syndrome.

What Is Qsymia?

Qsymia is a combination medication that contains two active ingredients: phentermine and topiramate extended-release. It's been FDA-approved for chronic weight management since 2012.

Phentermine is a stimulant that suppresses appetite, while topiramate is an anticonvulsant medication that has weight loss effects through several mechanisms, including increased feelings of fullness and possible changes in taste perception.

How Qsymia Works

The phentermine component in Qsymia works primarily as an appetite suppressant by affecting neurotransmitters in your brain. It's similar to an amphetamine and can increase heart rate and blood pressure.

Topiramate's exact mechanism for weight loss isn't fully understood, but it appears to enhance feelings of satiety, make food less appealing, and may slightly increase calorie burning. The combination of these two medications creates a more powerful effect than either ingredient alone.

Comparing Effectiveness

Both medication classes have demonstrated significant weight loss in clinical trials, though the results vary.

Clinical studies of GLP-1 medications show impressive results. Semaglutide trials have shown average weight loss of 15-20% of body weight over 68 weeks. Tirzepatide has demonstrated even more robust results, with some patients losing 20-25% of their body weight.

Qsymia studies show average weight loss ranging from 7-10% of body weight, depending on the dose used. While this is less than the newer GLP-1 medications, it still represents clinically meaningful weight loss that can improve health outcomes.

Considerations for Women

Women should be aware that Qsymia carries a serious pregnancy risk. Topiramate can cause birth defects, particularly cleft lip and cleft palate, if taken during pregnancy. Women of childbearing potential must use effective contraception and undergo pregnancy testing before starting and monthly during treatment.

GLP-1 medications should also be discontinued before planned pregnancy, but they don't carry the same level of birth defect risk as Qsymia.

Side Effects and Safety Profiles

Understanding potential side effects is crucial when choosing between these medications.

GLP-1 Side Effects

The most common side effects of GLP-1 medications are gastrointestinal. These include nausea, vomiting, diarrhea, constipation, and stomach discomfort. Most people find these symptoms are mild to moderate and improve over time as your body adjusts.

Serious side effects are rare but can include pancreatitis, gallbladder problems, and changes in heart rate. GLP-1 medications also carry a boxed warning about thyroid tumors seen in animal studies, though this hasn't been confirmed in humans.

Qsymia Side Effects

Common side effects of Qsymia include tingling in hands and feet (paresthesia), dizziness, altered taste, insomnia, constipation, and dry mouth. Because it contains a stimulant, Qsymia can increase heart rate and blood pressure.

More serious concerns include mood changes, depression, memory or concentration problems, and increased risk of kidney stones. The medication can also cause metabolic acidosis, a condition where your blood becomes too acidic.

Who Might Benefit From Each Medication

GLP-1 medications may be particularly well-suited for people who also have type 2 diabetes or prediabetes, as they provide blood sugar benefits alongside weight loss. They're also a good option for those who prefer a once-weekly injection over daily pills.

People with cardiovascular disease may benefit from GLP-1s, as some studies have shown cardiovascular protective effects beyond weight loss alone.

Qsymia might be considered for individuals who prefer oral medication, haven't responded to other weight loss treatments, or have no contraindications to stimulant medications. It's not appropriate for people with glaucoma, hyperthyroidism, or recent cardiovascular events.

Administration and Convenience

GLP-1 medications are administered as subcutaneous injections, typically once weekly. Modern injection pens are user-friendly with very small needles. Most people find the injections easy to do at home after initial instruction.

Qsymia is taken as an oral capsule once daily in the morning. The dose is typically started low and gradually increased to minimize side effects and find the most effective dose for you.

Cost Considerations

Cost can be a significant factor in choosing weight loss medication.

Brand-name GLP-1 medications can be expensive without insurance coverage, often costing $1,000 or more per month. However, compounded versions of semaglutide and tirzepatide have become available at more accessible price points.

Qsymia's cost varies depending on insurance coverage and dosage, typically ranging from $150-$250 per month without insurance. Some patients may find it more affordable than brand-name GLP-1 options.

From the Ozari Care Team

When comparing weight loss medications, there's no one-size-fits-all answer. The best choice depends on your individual health profile, medical history, and lifestyle preferences. We've found that GLP-1 medications offer not just weight loss, but improvements in metabolic health markers that extend beyond the scale, which is why they've become a cornerstone of our approach to sustainable weight management.

Making Your Decision

Choosing between GLP-1 medications and Qsymia should be a collaborative decision with your healthcare provider. Consider your medical history, other health conditions, medication preferences, potential side effects, and long-term sustainability.

Both medications require commitment to lifestyle changes including nutrition and physical activity for optimal results. Medication is a tool to support your efforts, not a replacement for healthy habits.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 29, 2026